Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
Clinical trial NCT00228605 · COMPLETED
Trial details
- NCT number
- NCT00228605
- Sponsor
- Cephalon
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.